The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure

European Journal of Health Economics

Volumn 12, Issue 4, 2011, Pages 383-391

  Kontodimopoulos, Nick ^a   Argiriou, Michalis ^a,b   Theakos, Nikolaos ^b   Niakas, Dimitris ^a  

^a HELLENIC OPEN UNIVERSITY   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Chronic heart failure; Cost utility analysis; Duke activity status index; EQ 5D; Health related quality of life; SF 6D

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; DUKE ACTIVITY STATUS INDEX; ELECTIVE SURGERY; EQ 5D; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART SURGERY; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 6D; CHRONIC DISEASE; COMPARATIVE STUDY; ECONOMICS; GREECE; HEALTH SURVEY; HOSPITALIZATION; INSTRUMENTATION; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; REPRODUCIBILITY; SELF EVALUATION; SICKNESS IMPACT PROFILE; SOCIOECONOMICS; STANDARD;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; GREECE; HEALTH STATUS INDICATORS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF-ASSESSMENT; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SOCIOECONOMIC FACTORS;

EID: 80052581023     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-010-0252-4     Document Type: Article

References (49)

1. McMurray, J.J., Pfeffer, M.A.: Heart failure. Lancet 365, 1877-1889 (2005) (Pubitemid 40744967)
2. Stewart, S., Jenkins, A., Buchan, S., McGuire, A., Capewell, S., McMurray, J.J.: The current cost of heart failure to the National Health Service in the UK. Eur. J. Heart Fail. 4, 361-371 (2002) (Pubitemid 35190362)
3. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., et al.: Heart disease and stroke statistics-2008 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 117, e25-e146 (2008)
4. Rich, M.W., Nease, R.F.: Cost-effectiveness analysis in clinical practice: the case of heart failure. Arch. Intern. Med. 159, 1690-1700 (1999) (Pubitemid 29379130)
5. Juenger, J., Schellberg, D., Kraemer, S., Haunstetter, A., Zugck, C., Herzog, W., et al.: Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 87, 235-241 (2002) (Pubitemid 34177677)
6. Hobbs, F.D., Kenkre, J.E., Roalfe, A.K., Davis, R.C., Hare, R., Davies, M.K.: Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur. Heart J. 23, 1867-1876 (2002) (Pubitemid 35398056)
7. Neubauer, S.: The failing heart - an engine out of fuel. N. Engl. J. Med. 356, 1140-1151 (2007) (Pubitemid 46425598)
8. Weintraub, W.S., Cole, J., Tooley, J.F.: Cost and cost-effectiveness studies in heart failure research. Am. Heart J. 143, 565-576 (2002) (Pubitemid 34454688)
9. Rasanen, P., Roine, E., Sintonen, H., Semberg-Konttinen, V., Ryynanen, O.P., Roine, R.: Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review. Int. J. Tech. Assess Health Care 22, 235-241 (2006)
10. Bryan, S., Longworth, L.: Measuring health-related utility: why the disparity between EQ-5D and SF-6D? Eur. J. Health Econ. 6, 253-260 (2005) (Pubitemid 41638849)
11. Bleichrodt, H.: A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Econ. 11, 447-456 (2002) (Pubitemid 34752615)
12. Green, C., Brazier, J., Deverill, M.: Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics 17, 151-165 (2000) (Pubitemid 30148812)
13. Dolan, P., Gudex, C., Kind, P., Williams, A.: Valuing health states: a comparison of methods. J. Health Econ. 15, 209-231 (1996) (Pubitemid 26290919)
14. Longworth, L., Bryan, S.: An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ. 12, 1061-1067 (2003) (Pubitemid 38035310)
15. Gerard, K., Nicholson, T., Mullee, M., Mehta, R., Roderick, P.: EQ-5D versus SF-6D in an older, chronically ill patient group. Appl. Health Econ. Health Policy 3, 91-102 (2004) (Pubitemid 41018307)
16. Lamers, L.M., Bouwmans, C.A., van Straten, A., Donker, M.C., Hakkaart, L.: Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ. 15, 1229-1236 (2006) (Pubitemid 44696950)
17. Xie, F., Li, S.C., Luo, N., Lo, N.N., Yeo, S.J., Yang, K.Y., et al.: Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement. Arthritis Rheum. 57, 1043-1049 (2007) (Pubitemid 47237332)
18. van Stel, H.F., Buskens, E.: Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health Qual. Life Outcomes 4, 20 (2006)
19. Grieve, R., Grishchenko, M., Cairns, J.: SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility. Eur. J. Health Econ. 10, 15-23 (2004)
20. Brazier, J., Roberts, J., Tsuchiya, A., Busschbach, J.: A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 13, 873-884 (2004) (Pubitemid 39264234)
21. Kontodimopoulos, N., Pappa, E., Papadopoulos, A.A., Tountas, Y., Niakas, D.: Comparing SF-6D and EQ-5D utilities across groups differing in health status. Qual. Life Res. 18, 87-97 (2009)
22. Barton, G.R., Sach, T.H., Avery, A.J., Doherty, M., Jenkinson, C., Muir, K.R.: Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain. Cost Eff. Resour. Alloc. 7, 12 (2009)
23. Petrou, S., Hockley, C.: An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Econ. 14, 1169-1189 (2005) (Pubitemid 41645379)
24. Bharmal, M., Thomas 3rd, J.: Comparing the EQ-5D and the SF- 6D descriptive systems to assess their ceiling effects in the US general population. Value Health 9, 262-271 (2006) (Pubitemid 44126781)
25. Barton, G.R., Sach, T.H., Avery, A.J., Jenkinson, C., Doherty, M., Whynes, D.K., et al.: A comparison of the performance of the EQ-5D and SF-6D for individuals aged[or = 45 years. Health Econ. 17, 815-832 (2008)
26. Tsevat, J., Duke, D., Goldman, L., Pfeffer, M.A., Lamas, G.A., Soukup, J.R., et al.: Cost-effectiveness of captopril therapy after myocardial infarction. J. Am. Coll. Cardiol. 26, 914-919 (1995)
27. Glick, H., Cook, J., Kinosian, B., Pitt, B., Bourassa, M.G., Pouleur, H., et al.: Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the studies of left ventricular dysfunction (SOLVD) treatment trial. J. Card. Fail. 1, 371-380 (1995)
28. National Institute for Clinical Excellence: Guide to the methods of technology appraisal. NICE, London (2004)
29. The EuroQol group: EuroQol - a new facility for the measurement of health related quality of life. Health Policy 16, 199-208 (1990)
30. Brooks, R.: EuroQol: the current state of play. Health Policy 37, 53-72 (1996) (Pubitemid 26191458)
31. Dolan, P.: Modeling valuations for EuroQol health states. Med. Care 35, 1095-1108 (1997) (Pubitemid 127453463)
32. Dolan, P., Gudex, C., Kind, P., Williams, A.: The time trade-off method: results from a general population study. Health Econ. 5, 141-154 (1996) (Pubitemid 126484860)
33. Yfantopoulos, J.: The Greek version of the EuroQol (EQ-5D) instrument. Arch. Hell. Med. 18, 180-191 (2001) (Pubitemid 33134326)
34. Kontodimopoulos, N., Pappa, E., Niakas, D., Yfantopoulos, J., Dimitrakaki, C., Tountas, Y.: Validity of the EQ-5D instrument in a Greek general population. Value Health 11, 1162-1169 (2008)
35. Brazier, J., Roberts, J., Deverill, M.: The estimation of a preference- based measure of health from the SF-36. J. Health Econ. 21, 271-292 (2002) (Pubitemid 34143147)
36. Pappa, E., Kontodimopoulos, N., Niakas, D.: Validating and norming of the Greek SF-36 health survey. Qual. Life Res. 14, 1433-1438 (2005) (Pubitemid 40895766)
37. Anagnostopoulos, F., Niakas, D., Pappa, E.: Construct validation of the Greek SF-36 health survey. Qual. Life Res. 14, 1959-1965 (2005) (Pubitemid 41279619)
38. Kontodimopoulos, N., Niakas, D.: A cost-utility analysis in renal replacement therapy based on patients' expected remaining life years. Health Policy 86, 85-96 (2008) (Pubitemid 351296306)
39. Hlatky, M.A., Boineau, R.E., Higginbotham, M.B., Lee, K.L., Mark, D.B., Califf, R.M., et al.: A brief self-administered questionnaire to determine functional capacity (The Duke activity status index). Am. J. Cardiol. 64, 651-654 (1989) (Pubitemid 19230238)
40. Mark, D.B., Naylor, C.D., Hlatky, M.A., Califf, R.M., Topol, E.J., Granger, C.B., et al.: Use of medical resources and quality of life after myocardial infarction in Canada and the United States. N. Engl. J. Med. 331, 1130-1135 (1994) (Pubitemid 24321219)
41. Pilote, L., Bourassa, M.G., Bacon, C., Bost, J., Detre, K., Mark, D.B., et al.: Better functional status in American than Canadian patients with heart disease: an effect of medical care? J. Am. Coll. Cardiol. 26, 1115-1120 (1995)
42. Roques, F., Nashef, S.A., Michel, P., Gauducheau, E., de Vincentiis, C., Baudet, E., et al.: Risk factors and outcome in European cardiac surgery: analysis of the Euro-SCORE multinational database of 19 030 patients. Eur. J. Cardiothorac. Surg. 15, 816-822 (1999)
43. Nashef, S.A., Roques, F., Michel, P., Gauducheau, E., Lemeshow, S., Salamon, R.: European system for cardiac operative risk evaluation (Euro-SCORE). Eur. J. Cardiothorac. Surg. 16, 9-13 (1999) (Pubitemid 29336425)
44. Cohen, J.: A power primer. Psychol. Bull. 112, 155-159 (1992)
45. Walters, S.J., Brazier, J.E.: What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual. Life Outcomes 1, 4 (2003)
46. Sullivan, P.W., Lawrence, W.F., Ghushchyan, V.: A national catalog of preference-based scores for chronic conditions in the United States. Med. Care 43, 736-749 (2005) (Pubitemid 40993769)
47. Walters, S.J., Brazier, J.E.: Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual. Life Res. 14, 1523-1532 (2005) (Pubitemid 40848233)
48. Nelson, C.L., Herndon, J.E., Mark, D.B., Pryor, D.B., Califf, R.M., Hlatky, M.A.: Relation of clinical and angiographic factors to functional capacity as measured by the Duke activity status index. Am. J. Cardiol. 68, 973-975 (1991)
49. Parissis, J.T., Nikolaou, M., Birmpa, D., Farmakis, D., Paraskevaidis, I., Bistola, V., et al.: Clinical and prognostic value of Duke's activity status index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 103, 73-75 (2009)